CN1136939A - Chinese drugs for curing hepatitis B - Google Patents
Chinese drugs for curing hepatitis B Download PDFInfo
- Publication number
- CN1136939A CN1136939A CN95116034A CN95116034A CN1136939A CN 1136939 A CN1136939 A CN 1136939A CN 95116034 A CN95116034 A CN 95116034A CN 95116034 A CN95116034 A CN 95116034A CN 1136939 A CN1136939 A CN 1136939A
- Authority
- CN
- China
- Prior art keywords
- radix
- rhizoma
- fructus
- medicine
- hepatitis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
A Chinese patent medicine in the form of pill, syrup or capsule for curing hepatitis B with 100% cure rate is prepared from 21 Chinese-medicinal materials such as astragalus root, ginseng, white atractylodes rhizome, tuckahoe, bupleurum root, etc. through crushing to obtain 120-mesh powder, or water decoction and concentration, addition of aged vinegar, ginger juice, or granular sugar, and making pills, syrup or capsules, and features leading curative effect, low cost and no toxic by-effect.
Description
The present invention relates to the medicine of the hundred-percent treatment hepatitis B of a kind of effective cure rate.It is to be the compound Chinese patent medicine of raw material outfit manufacturing by the multiple genuine Chinese medicine of selecting out among the Chinese medicine group.
The invention still further relates to this medicine honeyed pill, syrup, capsular processing preparation technique.
Hepatitis B is a kind of chronic infectious disease by the deficient initiation of body disease-resistant immunologic function.Hepatitis B virus (HIV) is though be its main source of disease body that brings out, and body disease-resistant regulating power and immune sterilizing function are deficient, and particularly local to carry out regulation and control association function deficient is that the basis with development takes place whole pathological changes to liver.After HIV infects human body, if body disease-resistant regulating power and immune sterilizing function prosperity have enough strength to eliminate evocating substances such as removing HIV, just pathological changes can not take place.Otherwise HIV etc. are fused in infected cell under the synergism of affine guiding material, discharge the excitation factor, and it is hyperfunction to bring out the liver function antagonism, causes a series of inflammatory reactions.Because the liver function antagonism is hyperfunction, synthetic and corresponding the increasing of release of material, with the passing of time then alluvial gradually causes the passages through which vital energy circulates pipeline to be obstructed, to conclude swollen tissue.Have in view of that, it is deficient that the whole pathological process of hepatitis B can summarize endogenous cause of ill, exopathogenic factor virus, and pathogenesis is not from general character such as alluvials.Hepatitis B recuperating medicine is peaceful to be that main purpose designs to restrain above-mentioned general character.
For the treatment of hepatitis B, the countries in the world experts and scholars are seeking good method, have paid hard work.Up to the present, can only lack the good plan that makes an initiative sally based on passive Supporting Therapy.Though clinical have antiviral therapy, immune modulating treatment, anti-infective therapy, liver protection treatment, a hormone therapy etc., curative effect is unsatisfactory, exists much to be difficult to the problem that solves.
1, HIV is difficult to eliminate removing, and the virus signature thing positive is difficult for turning out cloudy property;
2, the reparation difficulty of hepatic tissue infringement, fibrosclerosis easily, and even canceration;
3, symptom and sign and index such as chemical examination detections etc. the impermanence of bounce in therapeutic process, relapse rate is a hundred per cent almost.
The Chinese medicine hepatitis B presents the gratifying symptom of a trend, to liver function to resume treatment effect more satisfactory, after treatment, the abnormal liver function index all has recovery in various degree normal.But the solution to an above-mentioned difficult problem still makes little progress.
Drug therapy hepatitis B of the present invention not only can be recovered disease-resistant regulating power of enhancing body and immune sterilizing function.And can improve infected cell self identification dissident, eliminate the ability of removing viruses such as HIV.This medicine does not only have any injury to hepatic tissue and function to the HIV inhibitory or killing effect, and can protect and repair damaged tissue and function to greatest extent, promotes that pathological changes reverses fast.Again can the dredging the meridian pipeline, improve the liver material circulation, dissolve material alluvial swelling.Promote the supply of the nutrition energy to liver, the softening fibre sclerosis activates Telatrophy.Not only can eliminate the joint that is staggered to form because of hepatic tissue swelling and atrophy and tie concavo-convex focus, control sclerosis canceration.And can improve the physiological function that the local execution regulation and control of liver association function promotes to excite other internal organs by reparation, fundamentally cure hepatitis B, never recurrence after healing.
The purpose of this invention is to provide a kind of various types of hepatitis B patients that are widely used in, can eliminate viruses such as removing HIV effectively, the virus signature thing positives such as HBsAg, HBeAg, HBcAb are turned out cloudy.Promote damaged tissue and function to quicken to repair, improve fibrosclerosis, stop carcinous cancerating, fundamentally cure hepatitis B, the Chinese patent medicine compound preparation that never recurs after healing.
Second purpose of the present invention provides the processing outfit and the manufacturing technology of medicinal preparation for oral administration such as the peaceful medicine honeyed pill of hepatitis B recuperating medicine, syrup, capsule.
Design of the present invention is: deficient according to the hepatitis B endogenous cause of ill, exopathogenic factor virus, pathogenesis is not from the general character of depositing, should there be traditional Chinese medical science macroscopic view to distinguish that crux closes the method for doctor trained in Western medicine microcosmic differential diagnosis of diseases, therefrom select out tonify deficiency in the Drug Storage for a post and treat damage, but kill the virus, dissolve alluvial and wait the superior medicine of effect, be combined into the Chinese patent medicine of high-efficiency reliable treatment hepatitis B.
The optimum formula amounts of components ratio of medicine of the present invention is
The Radix Astragali 100 Radix Ginsengs 60 Rhizoma Atractylodis Macrocephalaes 60 Poria 60
Radix Bupleuri 100 Radix Paeoniae Albas 60 Fructus Aurantii Immaturuss 60 Radix Curcumaes 60
Radix Salviae Miltiorrhizae 100 Carapax Trionycis 60 Sal Nitri 60 Alumen 60
Fructus Schisandrae Chinensis 100 Radix Sophorae Tonkinensiss 60 Rhizoma Polygoni Cuspidati 60 Rhizoma Dioscoreae Bulbiferaes 60
Endothelium Corneum Gigeriae Galli 100 Fructus Hordei Germinatus 60 Fructus Crataegis 60 Radix Et Rhizoma Rhei 60
Yeast 100
Effective recipe ingredient usage ratio of medicine of the present invention is
The Radix Astragali 100 Radix Ginsengs 45 Rhizoma Atractylodis Macrocephalaes 45 Poria 60
Radix Bupleuri 90 Radix Paeoniae Albas 45 Fructus Aurantii Immaturuss 60 Radix Curcumaes 45
Radix Salviae Miltiorrhizae 90 Carapax Trionycis 45 Sal Nitri 30 Alumen 30
Fructus Schisandrae Chinensis 60 Radix Sophorae Tonkinensiss 45 Rhizoma Polygoni Cuspidati 60 Rhizoma Dioscoreae Bulbiferaes 45
Endothelium Corneum Gigeriae Galli 100 Fructus Hordei Germinatus 60 Fructus Crataegis 60 Radix Et Rhizoma Rhei 45
Yeast 60
The maximum constraints recipe ingredient usage ratio of medicine of the present invention is
The Radix Astragali 150 Radix Ginsengs 100 Rhizoma Atractylodis Macrocephalaes 120 Poria 150
Radix Bupleuri 150 Radix Paeoniae Albas 90 Fructus Aurantii Immaturuss 120 Radix Curcumaes 100
Radix Salviae Miltiorrhizae 150 Carapax Trionycis 100 Sal Nitri 60 Alumen 60
Fructus Schisandrae Chinensis 150 Radix Sophorae Tonkinensiss 100 Rhizoma Polygoni Cuspidati 150 Rhizoma Dioscoreae Bulbiferaes 100
Endothelium Corneum Gigeriae Galli 200 Fructus Hordei Germinatus 200 Fructus Crataegis 120 Radix Et Rhizoma Rhei 90
Yeast 150
The processing preparation technique of medicine honeyed pill of the present invention is
1, all medicine is given birth to usefulness, needn't anyly concoct;
2, get Rhizoma Zingiberis Recens and mash, 50 milliliters of extracting juice of extruding are standby;
3, the Radix Astragali, Radix Ginseng, the Rhizoma Atractylodis Macrocephalae, Poria, Radix Bupleuri, the Radix Paeoniae Alba, Fructus Aurantii Immaturus, Radix Curcumae, Radix Salviae Miltiorrhizae, Carapax Trionycis, Fructus Schisandrae Chinensis, Radix Sophorae Tonkinensis, Rhizoma Polygoni Cuspidati, Rhizoma Dioscoreae Bulbiferae, Endothelium Corneum Gigeriae Galli, Fructus Hordei Germinatus, Fructus Crataegi, Radix Et Rhizoma Rhei are processed into coarser powder by well-established law, mix with Sal Nitri, Alumen, yeast and to mix thoroughly, be ground into 120 order fine powders;
4, with 25 milliliters in mature vinegar, 50 milliliters of Rhizoma Zingiberis Recens juice mix with above-mentioned medicated powder to be mixed thoroughly, puts into wooden case, builds case lid, ferments 3 days;
5, take out medicated powder after three days, take out after 90 minutes, make honeyed pill by well-established law-12 ℃ of cold preservations.Every ball weighs 12 grams.
The processing preparation technique of medical syrup of the present invention is
1, all medicine is given birth to usefulness, needn't anyly concoct;
2, get Rhizoma Zingiberis Recens and mash, 30 milliliters of extracting juice of extruding are standby;
3, the Radix Astragali, Radix Ginseng, the Rhizoma Atractylodis Macrocephalae, Poria, Radix Bupleuri, the Radix Paeoniae Alba, Fructus Aurantii Immaturus, Radix Curcumae, Radix Salviae Miltiorrhizae, Carapax Trionycis, Radix Sophorae Tonkinensis, Rhizoma Polygoni Cuspidati, Rhizoma Dioscoreae Bulbiferae, Radix Et Rhizoma Rhei, Fructus Crataegi are processed into decoction pieces by well-established law, mix with Sal Nitri, Alumen, Fructus Schisandrae Chinensis, Endothelium Corneum Gigeriae Galli, Fructus Hordei Germinatus, yeast and put into the sand jar and decoct with water three times.For the first time add water and cross powder three fingers, boiled 90 minutes, take out medicinal liquid; For the second time add water and cross powder two fingers, boiled 60 minutes, take out medicinal liquid; Add water for the third time and cross powder one finger, boiled 30 minutes, take out medicinal liquid;
4, the medicinal residues after will decocting are mashed as mud, mix with three medicinal liquids and mix thoroughly, filter twice with two layers of hospital gauze, and with 20 milliliters in mature vinegar, 30 milliliters of Rhizoma Zingiberis Recens juice are put into marmite, and first intense fire, back slow fire are concentrated into every milliliter and contain 1 and restrain the crude drug amount;
5, the white sugar that adds every milliliter 1 gram content is while hot mixed thoroughly, is filtered, and makes nourushing syrup.
The processing preparation technique of medicament capsule of the present invention is
1, all medicine is given birth to usefulness, needn't anyly concoct;
2, get Rhizoma Zingiberis Recens and mash, 20 milliliters of extracting juice of extruding are standby;
3, get 1/2 of the Radix Astragali, Radix Ginseng, the Rhizoma Atractylodis Macrocephalae, Poria, Radix Bupleuri, the Radix Paeoniae Alba, Fructus Aurantii Immaturus, Radix Curcumae, Radix Salviae Miltiorrhizae, Carapax Trionycis, Alumen, Sal Nitri, Fructus Schisandrae Chinensis, Radix Sophorae Tonkinensis, Rhizoma Polygoni Cuspidati, Rhizoma Dioscoreae Bulbiferae, Endothelium Corneum Gigeriae Galli, Fructus Hordei Germinatus, Fructus Crataegi, each plant demand of Radix Et Rhizoma Rhei, whole mixing of yeast consumption are mixed thoroughly, are ground into 120 order fine powders;
4,1/2 decocting with the Radix Astragali, Radix Ginseng, the Rhizoma Atractylodis Macrocephalae, Poria, Radix Bupleuri, the Radix Paeoniae Alba, Fructus Aurantii Immaturus, Radix Curcumae, Radix Salviae Miltiorrhizae, Carapax Trionycis, Alumen, Sal Nitri, Fructus Schisandrae Chinensis, Radix Sophorae Tonkinensis, Rhizoma Polygoni Cuspidati, Rhizoma Dioscoreae Bulbiferae, Endothelium Corneum Gigeriae Galli, Fructus Hordei Germinatus, Fructus Crataegi, each plant demand of Radix Et Rhizoma Rhei boils three times.For the first time add water and cross powder three fingers, boiled 90 minutes, take out medicinal liquid; For the second time add water and cross powder two fingers, boiled 60 minutes, take out medicinal liquid; Add water for the third time and cross powder one finger, boiled 30 minutes, take out medicinal liquid;
5, mix three medicinal liquids, with 20 milliliters in mature vinegar, Rhizoma Zingiberis Recens juice is mixed thoroughly, is filtered for 20 milliliters;
6, medicinal liquid is poured in the medicated powder mixed thoroughly, pack in the sand jar, build cover.The sand jar is put into steamer, add water in the pot, the depth of water is with submergence sand jar 2/3 degree of being.Boiled 60-90 minute.Should note not allowing water immerse in the sand jar during steaming and decocting;
7, get clearance pot after the truce cooling, medicated powder is taken out in the sand jar, after-12 ℃ of freeze-drying lyophilizations, incapsulate by well-established law.Every capsule 0.5 gram.
Drug therapy hepatitis B adult's of the present invention consumption and instructions of taking are
1, honeyed pill: each 12 grams, every day 3 times, eliminating cold for resuscitation aquation clothes after meal.Child and old person's consumption cut down according to the circumstance;
2, syrup: each 15 milliliters, every day 3 times, directly oral after meal.Child and old person's consumption cut down according to the circumstance;
3, capsule: each 10 grams, every day 3 times, warm water delivery service after meal.Child and old person's consumption cut down according to the circumstance.
Drug study of the present invention studies have shown that following pharmacological action
1, strengthens hypophysis cerebri---adrenal cortex function, adjust the substance in vivo balance, improve the body disease-resistant regulating power;
2, excite T, bone-marrow-derived lymphocyte and NK cell activity, promote the generation and the function of specific immunity, improve infected cell recognition, separation, eliminating dissident's ability;
3, bring out interferon, improve the sensitivity that cell utilizes interferon, eliminate effectively and remove HIV etc. and bring out virus;
4, improve circulation, promote of the supply of the nutrition energy liver.Can hepatoprotective, enzyme falls.Improve serum albumin, reduce globulin;
5, promote to be compromised effective reparation of tissue and function, the joint knot shape that alluvial swelling of elimination hepatic tissue and atrophy sclerosis are staggered to form cancerates;
6, improve organism quality, strengthen the internal organs physiological function, fundamentally cure hepatitis B, no longer recurrence after healing.
Drug therapy hepatitis B of the present invention, the declarer has used more than two decades, has obtained the hundred-percent ideal effect of effective cure rate.Be to confirm clinical effectiveness, the hepatitis B 876 routine clinical data adjustment report of the receipts of freight and miscellany that now will use clever wind hepatitis B jinx treatment separately as after.Take medicine honeyed pill therapist 322 examples of the present invention and be the honeyed pill group, take medical syrup therapist 290 examples of the present invention and be the syrup group, take medicament capsule therapist 264 examples of the present invention and be Capsules group.Honeyed pill group male 224 examples, women's 98 examples; Age reckling 15 years old, the oldest person 64 years old.Syrup group male 206 examples, women's 84 examples; Age reckling 1.5 years old; The oldest person 65 years old.Capsules group male's 201 examples, women's 63 examples; Age reckling 18 years old, the oldest person 58 years old.All cases all meet the diagnostic criteria that national virus type hepatitis meeting is formulated in Shanghai May nineteen ninety.
Method of administration: each 12 grams of honeyed pill group, every day 3 times, eliminating cold for resuscitation aquation clothes after meal.Child and old person's consumption cut down according to the circumstance.Each 15 milliliters of syrup group, every day 3 times, directly oral after meal.Child and year person weakling consumption cut down according to the circumstance.Each 10 grams of Capsules group, every day 3 times, warm water delivery service after meal.Child and old person's consumption cut down according to the circumstance.
Observation item
1, degree is alleviated in the elimination of symptom and sign;
2, liver function index: serum total bilirubin (TBIL); Serum glutamic pyruvic transminase (ALT reitman-frankel method); Serum alkaline phosphatase (AKP King's method); Serum albumin egg (A); Globulin (G); Alpha-fetoprotein (AFP).
3, virus signature thing: HBsAg, HBeAg, HBcAb, DNA.
The result:
1,622 examples are all eliminated in symptom and sign treatment back, account for 70.8%; SPR 121 examples account for 13.8%, and part is alleviated 133 examples, accounts for 15.3%.The elimination alleviation degree of each group treatment back symptom and sign sees Table 1.
Degree is alleviated in the elimination of each group treatment back symptom of table 1 and sign
| Group | Total routine number | All eliminate | The most of disappearance | Part is alleviated | |||
| Example | ??％ | Example | ????％ | Example | ??％ | ||
| The honeyed pill group | ????322 | ??246 | ??74.2 | ????60 | ????18.6 | ????16 | ??7.2 |
| The syrup group | ????290 | ??211 | ??72.6 | ????29 | ????10 | ????50 | ??17.4 |
| Capsules group | ????264 | ??165 | ??62.4 | ????32 | ????12 | ????67 | ??25.6 |
2, liver function index: unusual 133 examples of TBIL before the treatment, normal 130 examples are recovered in the treatment back, account for 97.7%; Unusual 392 examples of ALT before the treatment, normal 386 examples are recovered in the treatment back, account for 98.4%; Unusual 119 examples of AKP before the treatment, normal 117 examples are recovered in the treatment back, account for 98.3%, unusual 124 examples of A before the treatment, normal 122 examples are recovered in the treatment back, account for 98.3%; Unusual 104 examples of G before the treatment, normal 102 examples are recovered in the treatment back, account for 98%; Unusual 14 examples of AFP before the treatment, normal 14 examples are recovered in the treatment back, account for 100%.Each is organized and the results are shown in Table 2 after the liver function index treatment.
Table 2 is respectively organized the result after the treatment of liver function index
| Group | Total routine number | ?????????TBIL | ?????????ALT | ?????????AKP | ???????????A | ???????????G | ???????????AFP | ||||||||||||
| Unusual before the treatment | Recover the treatment back | ?％ | Unusual before the treatment | Recover the treatment back | ?％ | Unusual before the treatment | Recover the treatment back | ?％ | Unusual before the treatment | Recover the treatment back | ?％ | Unusual before the treatment | Recover the treatment back | ?％ | Unusual before the treatment | Recover the treatment back | ?％ | ||
| The honeyed pill group | ??322 | ??53 | ??53 | 188 | 147 | ??146 | 99.3 | ??45 | ??45 | 188 | ??48 | ??48 | 188 | ??34 | ??34 | 188 | ????5 | ????5 | 188 |
| The syrup group | ??290 | ??41 | ??39 | 97 | 129 | ??126 | 97.7 | ??34 | ??32 | 94.1 | ??39 | ??38 | 99 | ??28 | ??28 | 188 | ????4 | ????4 | 188 |
| Capsules group | ??264 | ??39 | ??38 | 97.4 | 116 | ??114 | 98 | ??48 | ??49 | 188 | ??37 | ??36 | 97.2 | ??42 | ??49 | 95.2 | ????5 | ????5 | 188 |
3, virus signature thing, positive 876 examples of HBoAg before the treatment, treatment back 706 turning out cloudy property of example account for 80.3%; Positive 842 examples of HBeAg before the treatment, treatment back 816 turning out cloudy property of example account for 96.8%; Positive 854 examples of HBcAb before the treatment, treatment back 850 turning out cloudy property of example account for 97.8%.Each is organized hepatitis B replication label therapeutic outcome and sees Table 3.
Table 3 is respectively organized the therapeutic outcome of hepatitis B replication label
| Group | Total routine number | ?????????HBsAg | ????????HBeAg | ????????HBcAb | ?????????DNA | ||||||||
| Positive before the treatment | Turn out cloudy after the treatment | ?％ | Positive before the treatment | Turn out cloudy after the treatment | ??％ | Positive before the treatment | Turn out cloudy after the treatment | ?％ | Positive before the treatment | Turn out cloudy after the treatment | ?％ | ||
| The honeyed pill group | 322 | ?322 | ?280 | 86.9 | ?307 | ?299 | ?97.4 | ?311 | ?310 | 99.7 | ?296 | 290 | 98 |
| The syrup group | 290 | ?290 | ?205 | 70.7 | ?282 | ?274 | ?97.2 | ?286 | ?284 | 99.3 | ?263 | 258 | 98.1 |
| Capsules group | 264 | ?264 | ?221 | 84 | ?253 | ?243 | ?96.2 | ?257 | ?256 | 99.6 | ?237 | 231 | 97.4 |
The clinical treatment result of medicine of the present invention shows that also this medicine has following advantage
1, to select genuine Chinese medicine be raw material in the present invention, and each component meets the pharmaceutical control law regulation.Utilize the comprehensive function treatment hepatitis B effect of each medicine good, body is not had any injury, no toxicity.
2, medicine pure taste of the present invention need not decoct, and taking convenience is easy to carry.And cheap, the medicine source is abundant, helps promoting the use of.
3, medication effect of the present invention is good, and instant effect is stood checking repeatedly.Can fundamentally thoroughly cure hepatitis B, never recurrence after healing.
4, medicine of the present invention is not only cured hepatitis B, and the patient is had the nourishing the human Body effect.Reasonable distribution to the endotrophic material has facilitation.After taking, the patient can make that diet enhancement, weight increase, body constitution strengthen, brace up, the colour of skin is ruddy.
Claims (8)
1, the present invention is a kind of Chinese patent medicine of treatment hepatitis B of therapeutic effect excellence.It is characterized in that it is the medicament that is become by the processing and manufacturing of following weight proportion raw material.
The Radix Astragali 100 Radix Ginsengs 45 Rhizoma Atractylodis Macrocephalaes 45 Poria 60
Radix Bupleuri 90 Radix Paeoniae Albas 45 Fructus Aurantii Immaturuss 60 Radix Curcumaes 45
Radix Salviae Miltiorrhizae 90 Carapax Trionycis 45 Sal Nitri 30 Alumen 30
Fructus Schisandrae Chinensis 60 Radix Sophorae Tonkinensiss 45 Rhizoma Polygoni Cuspidati 60 Rhizoma Dioscoreae Bulbiferaes 45
Endothelium Corneum Gigeriae Galli 100 Fructus Hordei Germinatus 60 Fructus Crataegis 60 Radix Et Rhizoma Rhei 45
Yeast 60
2, according to the peaceful medicine of the described hepatitis B recuperating medicine of claim 1, wherein the deal proportion of each raw material of optimal dose is
The Radix Astragali 100 Radix Ginsengs 60 Rhizoma Atractylodis Macrocephalaes 60 Poria 60
Radix Bupleuri 100 Radix Paeoniae Albas 60 Fructus Aurantii Immaturuss 60 Radix Curcumaes 60
Radix Salviae Miltiorrhizae 100 Carapax Trionycis 60 Sal Nitri 60 Alumen 60
Fructus Schisandrae Chinensis 100 massif roots 60 Rhizoma Polygoni Cuspidati 60 Rhizoma Dioscoreae Bulbiferaes 60
Endothelium Corneum Gigeriae Galli 100 Fructus Hordei Germinatus 80 Fructus Crataegis 60 Radix Et Rhizoma Rhei 60
Yeast 100
3, according to the peaceful medicine of the described hepatitis B recuperating medicine of claim 1, wherein the deal proportion of each raw material of maximum limiting quantity is
The Radix Astragali 150 Radix Ginsengs 100 Rhizoma Atractylodis Macrocephalaes 120 Poria 150
Radix Bupleuri 150 Radix Paeoniae Albas 90 Fructus Aurantii Immaturuss 120 Radix Curcumaes 100
Radix Salviae Miltiorrhizae 150 Carapax Trionycis 100 Sal Nitri 60 Alumen 60
Fructus Schisandrae Chinensis 150 Radix Sophorae Tonkinensiss 100 Rhizoma Polygoni Cuspidati 150 Rhizoma Dioscoreae Bulbiferaes 100
Endothelium Corneum Gigeriae Galli 200 Fructus Hordei Germinatus 200 Fructus Crataegis 120 Radix Et Rhizoma Rhei 90
Yeast 150
4,, it is characterized in that said medicament and compound method are any pharmaceutics and the above any dosage form and compound method of saying of galenic pharmacy according to claim 1,2,3, the peaceful medicine of described hepatitis B recuperating medicine.
5,, it is characterized in that described pharmaceutical dosage form is a honey nine, syrup and capsule according to the peaceful medicine of the described hepatitis B recuperating medicine of claim 4.
6, according to the preparation technique of the peaceful medicine honey nine of the described hepatitis B recuperating medicine of claim 5, it is characterized in that the Radix Astragali, Radix Ginseng, the Rhizoma Atractylodis Macrocephalae, Poria, Radix Bupleuri, the Radix Paeoniae Alba, Fructus Aurantii Immaturus, Radix Curcumae, Radix Salviae Miltiorrhizae, Carapax Trionycis, Fructus Schisandrae Chinensis, Radix Sophorae Tonkinensis, Rhizoma Polygoni Cuspidati, Rhizoma Dioscoreae Bulbiferae, Endothelium Corneum Gigeriae Galli, Fructus Hordei Germinatus, Fructus Crataegi, Radix Et Rhizoma Rhei are processed into coarser powder by well-established law, mix with Sal Nitri, Alumen, yeast and to mix thoroughly, be ground into 120 order fine powders, with 25 milliliters in mature vinegar, Rhizoma Zingiberis Recens juice is mixed thoroughly for 50 milliliters, put into wooden case, ferment and take out after 3 days,-12 ℃ of cold preservations 90 minutes, make honey nine, per nine heavy 12 grams by well-established law.
7, according to the preparation technique of the peaceful medical syrup of the described hepatitis B recuperating medicine of claim 5, it is characterized in that the Radix Astragali, Radix Ginseng, the Rhizoma Atractylodis Macrocephalae, Poria, Radix Bupleuri, the Radix Paeoniae Alba, Fructus Aurantii Immaturus, Radix Curcumae, Radix Salviae Miltiorrhizae, Carapax Trionycis, Radix Sophorae Tonkinensis, Rhizoma Polygoni Cuspidati, Rhizoma Dioscoreae Bulbiferae, Radix Et Rhizoma Rhei, Fructus Crataegi are processed into decoction pieces by well-established law, mix with Sal Nitri, Alumen, Fructus Schisandrae Chinensis, Endothelium Corneum Gigeriae Galli, Fructus Hordei Germinatus, yeast and put into the sand jar and decoct with water three times.For the first time add water and cross powder three fingers, boiled 90 minutes, take out medicinal liquid; For the second time add water and cross powder two fingers, boiled 60 minutes, take out medicinal liquid; Add water for the third time and cross powder one finger, boiled 30 minutes, and took out medicinal liquid, medicinal residues are mashed as mud, mix with three medicinal liquids and to mix filtration thoroughly, with 20 milliliters in mature vinegar, 30 milliliters of Rhizoma Zingiberis Recens juice are put into marmite, elder generation's intense fire, back slow fire is concentrated into every milliliter and contains 1 gram crude drug amount, adds the white sugar of every milliliter 1 gram content, makes nourushing syrup.
8, preparation technique according to the peaceful medicament capsule of the described hepatitis B recuperating medicine of claim 5, it is characterized in that getting the Radix Astragali, Radix Ginseng, the Rhizoma Atractylodis Macrocephalae, Poria, Radix Bupleuri, the Radix Paeoniae Alba, Fructus Aurantii Immaturus, Radix Curcumae, Radix Salviae Miltiorrhizae, Carapax Trionycis, Alumen, Sal Nitri, Fructus Schisandrae Chinensis, Radix Sophorae Tonkinensis, Rhizoma Polygoni Cuspidati, Rhizoma Dioscoreae Bulbiferae, Endothelium Corneum Gigeriae Galli, Fructus Hordei Germinatus, Fructus Crataegi, 1/2 of each plant demand of Radix Et Rhizoma Rhei, it is standby that yeast consumption whole are ground into 120 order fine powders, again with the Radix Astragali, Radix Ginseng, the Rhizoma Atractylodis Macrocephalae, Poria, Radix Bupleuri, the Radix Paeoniae Alba, Fructus Aurantii Immaturus, Radix Curcumae, Radix Salviae Miltiorrhizae, Carapax Trionycis, Sal Nitri, Alumen, Fructus Schisandrae Chinensis, Radix Sophorae Tonkinensis, Rhizoma Polygoni Cuspidati, Rhizoma Dioscoreae Bulbiferae, Endothelium Corneum Gigeriae Galli, Fructus Hordei Germinatus, Fructus Crataegi, 1/2 of each plant demand of Radix Et Rhizoma Rhei decocts three times.For the first time add water and cross powder three fingers, boiled 90 minutes, take out medicinal liquid; For the second time add water and cross powder two fingers, boiled 60 minutes, take out medicinal liquid; Add water for the third time and cross powder one finger, boiled 30 minutes, take out medicinal liquid, mix three times medicinal liquid, with 20 milliliters in mature vinegar, 20 milliliters of Rhizoma Zingiberis Recens juice, filter, the medicinal liquid example is gone in the medicated powder to mix thoroughly, pack in the sand jar, build cover, the sand jar is put into steamer, add water in the pot,, boiled 60-90 minute with submergence sand jar 2/3 degree of being.Should note to allow water immerse in the sand jar during steaming and decocting, incapsulate after medicated powder, drying are taken out in the cooling back, every capsule 0.5 gram.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN95116034A CN1058165C (en) | 1995-10-10 | 1995-10-10 | Chinese drugs for curing hepatitis B |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN95116034A CN1058165C (en) | 1995-10-10 | 1995-10-10 | Chinese drugs for curing hepatitis B |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1136939A true CN1136939A (en) | 1996-12-04 |
| CN1058165C CN1058165C (en) | 2000-11-08 |
Family
ID=5080743
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN95116034A Expired - Fee Related CN1058165C (en) | 1995-10-10 | 1995-10-10 | Chinese drugs for curing hepatitis B |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1058165C (en) |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1061885C (en) * | 1997-09-18 | 2001-02-14 | 李良云 | Specific infusion for hepatitis B and producing process thereof |
| CN1066341C (en) * | 1997-10-20 | 2001-05-30 | 王兴体 | Chinese medicine for treating hepatitis B and preparing process thereof |
| CN1067267C (en) * | 1998-04-24 | 2001-06-20 | 汪东平 | Medicine for treating hepatitis B |
| CN101199606B (en) * | 2006-12-14 | 2012-05-09 | 北京因科瑞斯生物制品研究所 | Medicament for treating liver disease |
| CN103948875A (en) * | 2014-05-13 | 2014-07-30 | 梁景山 | Medicine for treating hepatitis B and preparation method thereof |
| CN107343948A (en) * | 2017-08-04 | 2017-11-14 | 成都市飞龙水处理技术研究所 | It is a kind of effectively to treat pill medicine of hepatitis B and preparation method thereof |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1035924C (en) * | 1993-02-26 | 1997-09-24 | 王旭中 | Chinese patent drug "ganaoling" for treating hepatitis |
| CN1108943A (en) * | 1994-03-21 | 1995-09-27 | 李春祥 | Medicine "Yigankang" for hepatitis B and its preparation |
-
1995
- 1995-10-10 CN CN95116034A patent/CN1058165C/en not_active Expired - Fee Related
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1061885C (en) * | 1997-09-18 | 2001-02-14 | 李良云 | Specific infusion for hepatitis B and producing process thereof |
| CN1066341C (en) * | 1997-10-20 | 2001-05-30 | 王兴体 | Chinese medicine for treating hepatitis B and preparing process thereof |
| CN1067267C (en) * | 1998-04-24 | 2001-06-20 | 汪东平 | Medicine for treating hepatitis B |
| CN101199606B (en) * | 2006-12-14 | 2012-05-09 | 北京因科瑞斯生物制品研究所 | Medicament for treating liver disease |
| CN103948875A (en) * | 2014-05-13 | 2014-07-30 | 梁景山 | Medicine for treating hepatitis B and preparation method thereof |
| CN107343948A (en) * | 2017-08-04 | 2017-11-14 | 成都市飞龙水处理技术研究所 | It is a kind of effectively to treat pill medicine of hepatitis B and preparation method thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1058165C (en) | 2000-11-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1044974C (en) | Anti- hepatitis B preparation | |
| CN1047946C (en) | Preparation for treating senile diseases | |
| CN1194843A (en) | Method for producing green health medicine | |
| CN1255181C (en) | Preparation of medicinal composition for nourishing | |
| CN1895619A (en) | Chinese-medicinal composition for preventing and treating liver disease and its preparation | |
| CN1058165C (en) | Chinese drugs for curing hepatitis B | |
| CN100340286C (en) | Medicine for treating hepatitis B and its preparing process | |
| CN1739753A (en) | Psoriasis treating Chinese medicine prepn and its pren process | |
| CN1111046C (en) | Chinese medicine preparation for curing postpartum disease of woman | |
| CN101199749A (en) | Chinese medicine for treating AIDS | |
| CN1223886A (en) | Pathogenic factor eliminating and healthy energy supporting anticancer medicine | |
| CN100360156C (en) | Chinese medicine composition new use | |
| CN1059104C (en) | Capsule for anti hepatitis B | |
| CN1302799C (en) | Oral Chinese medicinal composition for treating virus myocarditis | |
| CN1130529A (en) | Aizikangfuning-Chinese patent drug for treating AIDS and preparing process thereof | |
| CN101015636A (en) | Novel use of Chinese-medicinal composition | |
| CN1195541C (en) | Medicine combination for treating chronic hepatitis B | |
| CN1063077C (en) | Traditional Chinese medicine composition for lowering blood-lipid, and method for preparing same | |
| CN1113804A (en) | Antianemic powder and its preparing method | |
| CN1079396A (en) | Intelligence-enhancing pharmaceutical preparation | |
| CN111375036B (en) | Traditional Chinese medicine composition for treating novel coronavirus pneumonia and application thereof | |
| CN1126558C (en) | Medicine for treating kidney damage caused by immunological disease lupus erythematosus | |
| CN1076622C (en) | Chinese medicine for curing nephritis | |
| CN1244339C (en) | Chinese medicine for treating and preventing fatty liver and its preparing process | |
| CN1836705A (en) | Medicine for treating amblyopia and its preparing method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |